These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 32550700)

  • 21. lncRNA BCAR4 Increases Viability, Invasion, and Migration of Non-Small Cell Lung Cancer Cells by Targeting Glioma-Associated Oncogene 2 (
    Yang H; Yan L; Sun K; Sun X; Zhang X; Cai K; Song T
    Oncol Res; 2019 Feb; 27(3):359-369. PubMed ID: 29615150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
    Dong YZ; Meng XM; Li GS
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B; Tang Z; Gong H; Zhu L; Liu X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHB2 promotes tumorigenesis
    Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
    Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
    [No Abstract]   [Full Text] [Related]  

  • 30. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
    Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
    Lin X; Chang W; Wang Y; Tian M; Yu Z
    Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways.
    Liao L; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
    Int J Biol Sci; 2019; 15(1):183-194. PubMed ID: 30662358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JMJD3 enhances invasiveness and migratory capacity of non-small cell lung cancer cell via activating EMT signaling pathway.
    Zhang Y; Hua PY; Jin CY; Li JD; Zhang GX; Wang B
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4784-4792. PubMed ID: 31210309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
    Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
    Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
    Wu Z; He D; Zhao S; Wang H
    Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis.
    Gao J; Song L; Xia H; Peng L; Wen Z
    Respir Res; 2020 Feb; 21(1):39. PubMed ID: 32014006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.